# China NMPA Product Recall - X-Force N30 Nephrostomy Ballcon Dilation Catheter

Source: https://www.globalkeysolutions.net/records/china_product_recall/cr-bard-inc/79b083e0-55f3-4911-aa59-bd4946873e8b/
Source feed: China

> China NMPA product recall for X-Force N30 Nephrostomy Ballcon Dilation Catheter by C.R. Bard, Inc. published January 09, 2017. Recall level: Level 3 Recall. Bard Medical Technology (Shanghai) Co., Ltd., under the regulatory oversight of the National Medical

---

## Details

- Record Type: CHINA_PRODUCT_RECALL
- Title: Bard Medical Technology (Shanghai) Co., Ltd. is voluntarily recalling its nephrostomy balloon dilation catheter.
- Company Name: C.R. Bard, Inc.
- Publication Date: 2017-01-09
- Product Name: X-Force N30 Nephrostomy Ballcon Dilation Catheter
- Recall Level: Level 3 Recall
- Recall Reason: For product X-Force N30 Nephrostomy Balloon Dilarion Catheter, code 956081 wes incorrectly packaged with: 30Fr sheaths which correct shesth size should be 24 Fr.
- Discovering Company: Bard Medical Technology (Shanghai) Co., Ltd.
- Manufacturing Company: C.R. Bard, Inc.
- Summary: Bard Medical Technology (Shanghai) Co., Ltd., under the regulatory oversight of the National Medical Products Administration (NMPA) of China, initiated a voluntary product recall for its X-Force N30 Nephrostomy Balloon Dilation Catheter. The recall, reported on October 25, 2016, and published on January 9, 2017, involved 177 units distributed across the U.S., Europe, and China, with 170 units specifically identified for the Chinese market. The primary issue identified was a critical packaging error for product code 956081. The affected catheter packages incorrectly contained a 30 French (Fr) sheath, whereas the intended and correct size for this product was 24 Fr. This discrepancy in sheath size poses a significant concern for patient safety and product efficacy, as the use of an incorrect size could lead to procedural complications or adverse events during nephrostomy tract dilation and working sheath placement. Under the NMPA's medical device recall framework, Bard Medical Technology was required to implement several corrective actions. These included an immediate halt to the distribution and use of all affected products. Furthermore, the company mandated the quarantine of all recalled units and initiated notifications to relevant distributors and hospitals, instructing them to return the non-conforming products. These measures aim to prevent further use of the mispackaged devices and mitigate potential risks to patients.

Company: https://www.globalkeysolutions.net/companies/cr-bard-inc/a7ce11fc-82cf-46f7-96eb-b80625da02e3/